Jpmorgan Chase & Co »

Rigel Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $186k 128k 1.45
2023-09-30 $231k 214k 1.08
2023-06-30 $350k 271k 1.29
2023-03-31 $515k 390k 1.32
2022-12-31 $258k 172k 1.50
2022-06-30 $107k 95k 1.13
2022-03-31 $0 95k 0.00
2021-12-31 $0 76k 0.00
2021-03-31 $0 64k 0.00
2020-12-31 $2.0M 581k 3.50
2020-09-30 $145k 63k 2.29
2020-06-30 $743k 404k 1.84
2020-03-31 $990k 634k 1.56
2019-12-31 $397k 186k 2.14
2019-09-30 $103k 55k 1.87
2019-06-30 $1.4M 591k 2.45
2019-03-31 $105k 41k 2.56
2018-12-31 $99k 43k 2.31
2018-09-30 $435k 135k 3.21
2018-06-30 $4.0M 1.4M 2.83
2018-03-31 $7.2M 2.0M 3.54
2017-12-31 $5.3M 1.4M 3.88
2017-06-30 $4.0M 1.5M 2.73
2017-03-31 $4.8M 1.4M 3.31
2016-12-31 $4.2M 1.8M 2.38
2016-09-30 $7.9M 2.2M 3.67
2016-06-30 $3.5M 1.6M 2.23
2013-12-31 $31k 11k 2.81
2013-09-30 $327k 91k 3.58
2013-06-30 $213k 64k 3.34
2012-06-30 $453k 46k 9.84
2010-12-31 $326k 49k 6.59